Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Cross-sectional Study of a Prototype Carcinogenic Human Papillomavirus E6/E7 Messenger RNA Assay for Detection of Cervical Precancer and Cancer

1 May 2007

Abstract excerpt

PURPOSE: To evaluate carcinogenic human papillomavirus (HPV) mRNA for E6 and E7 mRNA detection on clinical specimens to identify women with cervical precancer and cancer. EXPERIMENTAL DESIGN: We evaluated a prototype assay that collectively detects oncogenes E6/E7 mRNA for 14 carcinogenic HPV genotypes on a sample of liquid cytology specimens (n=531), masked to clinical data and to the presence of HPV genotypes...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cervical Cancer and HPV Research
Share to Endometrial and Cervical Cancer Treatments
Share to Head and Neck Cancer Studies

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 17473189
DOI: 10.1158/1078-0432.ccr-06-2881

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Cross-sectional Study of a Prototype Carcinogenic Human Papillomavirus E6/E7 Messenger RNA Assay for Detection of Cervical Precancer and CancerPMID 17473189Read ↗

HPV E6 and E7 mRNA Test for the Detection of High-Grade Cervical LesionsSemantic proximity Read ↗

Assessment of human papillomavirus E6/E7 oncogene expression as cervical disease biomarkerSemantic proximity Read ↗

The value of high-risk HPV E6/E7 mRNA test positivity with NILM cytology in detecting cervical squamous intraepithelial lesions and cervical cancerSemantic proximity Read ↗

Type‐specific human papillomavirus oncogene messenger RNA levels correlate with the severity of cervical neoplasiaSemantic proximity Read ↗

HPV E6/E7 mRNA versus HPV DNA biomarker in cervical cancer screening of a group of Macedonian womenSemantic proximity Read ↗

Human Papillomavirus E6/E7 oncogene transcripts as biomarkers for the early detection of cervical cancerSemantic proximity Read ↗

Distribution of human papilloma virus type 16 E6/E7 gene mutation in cervical precancer or cancer: A case control study in Guizhou Province, China.Semantic proximity Read ↗

Comparison of oncogenic HPV type-specific viral DNA load and E6/E7 mRNA detection in cervical samples: results from a multicenter study.Semantic proximity Read ↗

Clinical Performance of Human Papillomavirus E6 and E7 mRNA Testing for High-Grade Lesions of the CervixSemantic proximity Read ↗

Performance of human papillomavirus DNA and mRNA testing strategies for women with and without cervical neoplasia.Semantic proximity Read ↗

Single-tube multiplex PCR using type-specific E6/E7 primers and capillary electrophoresis genotypes 21 human papillomaviruses in neoplasiaSemantic proximity Read ↗

Use of hTERT and HPV E6/E7 mRNA RT-qPCR TaqMan assays in combination for diagnosing high-grade cervical lesions and malignant tumors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.